Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins.

Cefaclor, a second-generation oral cephalosporin, is the most frequently prescribed cephalosporin in Korea. Studies, however, have yet to analyze the incidence of cefaclor-associated adverse drug reactions (ADRs), including hypersensitivity (HS), according to total national usage rates. This study a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hyo-In Rhyou, Young-Hee Nam, Su-Chin Kim, Go-Eun Doo, Chae-Yeon Ha, Hee-Joo Nam, Sung-Dae Woo, Youngsoo Lee, Jae-Hyuk Jang, Hyun-Young Lee, Young-Min Ye
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/fe0e3991d6c34fa890f1b2fb821859ad
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fe0e3991d6c34fa890f1b2fb821859ad
record_format dspace
spelling oai:doaj.org-article:fe0e3991d6c34fa890f1b2fb821859ad2021-12-02T20:04:57ZCefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins.1932-620310.1371/journal.pone.0254898https://doaj.org/article/fe0e3991d6c34fa890f1b2fb821859ad2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0254898https://doaj.org/toc/1932-6203Cefaclor, a second-generation oral cephalosporin, is the most frequently prescribed cephalosporin in Korea. Studies, however, have yet to analyze the incidence of cefaclor-associated adverse drug reactions (ADRs), including hypersensitivity (HS), according to total national usage rates. This study aimed to investigate the incidence rates and clinical features of cefaclor ADRs reported to the Korean Adverse Event Reporting System (KAERS) and Health Insurance Review and Assessment Service (HIRA) database for the most recent 5 years. Reviewing the HIRA database, which contains information on all insurance claims, including prescribed medications and patient demographics, we identified the total number of individuals who had been prescribed cefaclor and other cephalosporins including 2nd generation without cefaclor and 3rd generation antibiotics from January 2014 to December 2018. Additionally, we retrospectively analyzed all ADRs reported to the KAERS for these drugs over the same study period. Incidence rates for ADRs, HS, and anaphylaxis to cefaclor were 1.92/10,000 persons, 1.17/10,000 persons, and 0.38/10,000 persons, respectively, lower than those to other 2nd and 3rd cephalosporins. Among all ADRs, HS (60.9% vs. 43.6% vs. 44.8%, P <0.001) and anaphylaxis (19.8% vs. 4.6% vs. 4.7%, P <0.001) were more common for cefaclor than for other 2nd and 3rd cephalosporins. Females, individuals under 65 years of age, concomitant use of drugs, and serious ADRs were more strongly associated with HS to cefaclor than with HS to other 2nd and 3rd cephalosporins. In a nationwide database for the Korean population, the incidence of cefaclor-induced ADRs, particularly HS and anaphylaxis, was high. Female sex, age younger than 65 years, and concomitant use of drugs may be associated with HS to cefaclor.Hyo-In RhyouYoung-Hee NamSu-Chin KimGo-Eun DooChae-Yeon HaHee-Joo NamSung-Dae WooYoungsoo LeeJae-Hyuk JangHyun-Young LeeYoung-Min YePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0254898 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hyo-In Rhyou
Young-Hee Nam
Su-Chin Kim
Go-Eun Doo
Chae-Yeon Ha
Hee-Joo Nam
Sung-Dae Woo
Youngsoo Lee
Jae-Hyuk Jang
Hyun-Young Lee
Young-Min Ye
Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins.
description Cefaclor, a second-generation oral cephalosporin, is the most frequently prescribed cephalosporin in Korea. Studies, however, have yet to analyze the incidence of cefaclor-associated adverse drug reactions (ADRs), including hypersensitivity (HS), according to total national usage rates. This study aimed to investigate the incidence rates and clinical features of cefaclor ADRs reported to the Korean Adverse Event Reporting System (KAERS) and Health Insurance Review and Assessment Service (HIRA) database for the most recent 5 years. Reviewing the HIRA database, which contains information on all insurance claims, including prescribed medications and patient demographics, we identified the total number of individuals who had been prescribed cefaclor and other cephalosporins including 2nd generation without cefaclor and 3rd generation antibiotics from January 2014 to December 2018. Additionally, we retrospectively analyzed all ADRs reported to the KAERS for these drugs over the same study period. Incidence rates for ADRs, HS, and anaphylaxis to cefaclor were 1.92/10,000 persons, 1.17/10,000 persons, and 0.38/10,000 persons, respectively, lower than those to other 2nd and 3rd cephalosporins. Among all ADRs, HS (60.9% vs. 43.6% vs. 44.8%, P <0.001) and anaphylaxis (19.8% vs. 4.6% vs. 4.7%, P <0.001) were more common for cefaclor than for other 2nd and 3rd cephalosporins. Females, individuals under 65 years of age, concomitant use of drugs, and serious ADRs were more strongly associated with HS to cefaclor than with HS to other 2nd and 3rd cephalosporins. In a nationwide database for the Korean population, the incidence of cefaclor-induced ADRs, particularly HS and anaphylaxis, was high. Female sex, age younger than 65 years, and concomitant use of drugs may be associated with HS to cefaclor.
format article
author Hyo-In Rhyou
Young-Hee Nam
Su-Chin Kim
Go-Eun Doo
Chae-Yeon Ha
Hee-Joo Nam
Sung-Dae Woo
Youngsoo Lee
Jae-Hyuk Jang
Hyun-Young Lee
Young-Min Ye
author_facet Hyo-In Rhyou
Young-Hee Nam
Su-Chin Kim
Go-Eun Doo
Chae-Yeon Ha
Hee-Joo Nam
Sung-Dae Woo
Youngsoo Lee
Jae-Hyuk Jang
Hyun-Young Lee
Young-Min Ye
author_sort Hyo-In Rhyou
title Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins.
title_short Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins.
title_full Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins.
title_fullStr Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins.
title_full_unstemmed Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins.
title_sort cefaclor-induced hypersensitivity: differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/fe0e3991d6c34fa890f1b2fb821859ad
work_keys_str_mv AT hyoinrhyou cefaclorinducedhypersensitivitydifferencesintheincidenceofanaphylaxisrelativetoother2ndand3rdgenerationcephalosporins
AT youngheenam cefaclorinducedhypersensitivitydifferencesintheincidenceofanaphylaxisrelativetoother2ndand3rdgenerationcephalosporins
AT suchinkim cefaclorinducedhypersensitivitydifferencesintheincidenceofanaphylaxisrelativetoother2ndand3rdgenerationcephalosporins
AT goeundoo cefaclorinducedhypersensitivitydifferencesintheincidenceofanaphylaxisrelativetoother2ndand3rdgenerationcephalosporins
AT chaeyeonha cefaclorinducedhypersensitivitydifferencesintheincidenceofanaphylaxisrelativetoother2ndand3rdgenerationcephalosporins
AT heejoonam cefaclorinducedhypersensitivitydifferencesintheincidenceofanaphylaxisrelativetoother2ndand3rdgenerationcephalosporins
AT sungdaewoo cefaclorinducedhypersensitivitydifferencesintheincidenceofanaphylaxisrelativetoother2ndand3rdgenerationcephalosporins
AT youngsoolee cefaclorinducedhypersensitivitydifferencesintheincidenceofanaphylaxisrelativetoother2ndand3rdgenerationcephalosporins
AT jaehyukjang cefaclorinducedhypersensitivitydifferencesintheincidenceofanaphylaxisrelativetoother2ndand3rdgenerationcephalosporins
AT hyunyounglee cefaclorinducedhypersensitivitydifferencesintheincidenceofanaphylaxisrelativetoother2ndand3rdgenerationcephalosporins
AT youngminye cefaclorinducedhypersensitivitydifferencesintheincidenceofanaphylaxisrelativetoother2ndand3rdgenerationcephalosporins
_version_ 1718375581237641216